Come up with a name for your new list and we'll add to it:
Somantix raised a round of funding on January 01, 2008. Investors include
Aglaia Biomedical Ventures.
SomantiX is a Dutch biotech company SomantiX focuses on the development of therapeutics of solid cancers through direct targeting tumor blood vessels. The SomantiX R&D programs focus on target discove…